(Q43704020)

English

Thiazolidinediones, peroxisome proliferator-activated receptor gamma agonists, regulate endothelial cell growth and secretion of vasoactive peptides

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 November 2017

Thiazolidinediones, peroxisome proliferator-activated receptor gamma agonists, regulate endothelial cell growth and secretion of vasoactive peptides (English)

1 reference

Europe PubMed Central

26 November 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Fukunaga Y

1

1 reference

Europe PubMed Central

26 November 2017

Itoh H

2

1 reference

Europe PubMed Central

26 November 2017

Doi K

3

1 reference

Europe PubMed Central

26 November 2017

Tanaka T

4

1 reference

Europe PubMed Central

26 November 2017

Yamashita J

5

1 reference

Europe PubMed Central

26 November 2017

Chun TH

6

1 reference

Europe PubMed Central

26 November 2017

Inoue M

7

1 reference

Europe PubMed Central

26 November 2017

Masatsugu K

8

1 reference

Europe PubMed Central

26 November 2017

Sawada N

9

1 reference

Europe PubMed Central

26 November 2017

Saito T

10

1 reference

Europe PubMed Central

26 November 2017

Hosoda K

11

1 reference

Europe PubMed Central

26 November 2017

Kook H

12

1 reference

Europe PubMed Central

26 November 2017

Ueda M

13

1 reference

Europe PubMed Central

26 November 2017

Nakao K

14

1 reference

Europe PubMed Central

26 November 2017

publication date

1 September 2001

1 reference

Europe PubMed Central

26 November 2017

Atherosclerosis

1 reference

Europe PubMed Central

26 November 2017

158

1 reference

Europe PubMed Central

26 November 2017

1

1 reference

Europe PubMed Central

26 November 2017

113-119

1 reference

Europe PubMed Central

26 November 2017

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

Down regulation of peroxisome proliferator-activated receptorgamma expression by inflammatory cytokines and its reversal by thiazolidinediones

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

Blood pressure lowering by pioglitazone. Evidence for a direct vascular effect

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

C-type natriuretic peptide in human coronary atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system"

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

Autocrine activities of basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

Vascular natriuretic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

PPARgamma activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARgamma as a potential mediator in vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

Thiazolidinediones down-regulate plasminogen activator inhibitor type 1 expression in human vascular endothelial cells: A possible role for PPARgamma in endothelial function.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

PPARgamma agonists enhance human vascular endothelial adhesiveness by increasing ICAM-1 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

Troglitazone-induced fulminant hepatic failure. Acute Liver Failure Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

Endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-Delta12, 14-prostaglandin J2

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

Thiazolidinediones suppress endothelin-1 secretion from bovine vascular endothelial cells: a new possible role of PPARgamma on vascular endothelial function.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

Regulation of endothelial production of C-type natriuretic peptide in coculture with vascular smooth muscle cells. Role of the vascular natriuretic peptide system in vascular growth inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

Increasing insulin sensitivity lowers blood pressure in the fructose-fed rat

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

Chronic hyperglycemia impairs endothelial function and insulin sensitivity via different mechanisms in insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

Identifiers

10.1016/S0021-9150(01)00430-0

1 reference

Europe PubMed Central

26 November 2017

1 reference

Europe PubMed Central

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43704020&oldid=2164758729"